查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1411355

肛門瘺治療市場：按治療類型、瘻管類型、最終用戶分類 - 全球預測 2024-2030

Anal Fistula Treatment Market by Treatment Type (Non-Surgical, Surgical), Fistula Type (Intersphincteric Fistula, Suprasphincteric Fistula, Transsphincteric Fistula), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年肛瘺治療市場規模為6.5139億美元，預計2024年將達6.7552億美元，2030年將達9.091億美元，複合年成長率為4.87%。

全球肛門瘺治療市場

主要市場統計
基準年[2023] 65139萬美元
預測年份 [2024] 67552萬美元
預測年份 [2030] 9.091 億美元
複合年成長率（%） 4.87%
肛門瘺治療市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估肛門瘺治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對肛瘺治療市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-肛瘺治療市場的市場規模與預測是多少？

2-在肛瘺治療市場的預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-肛瘺治療市場的技術趨勢和法律規範是什麼？

4-肛瘺治療市場主要廠商的市場佔有率是多少？

5-進入肛瘺治療市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球肛門瘺盛行率上升
      • 微創手術趨勢
      • 提高肛瘺治療藥物和治療方法的核准率
    • 抑制因素
      • 肛瘺治療費用高
    • 機會
      • 肛瘺治療方法介紹
      • 用於開發增強藥物和治療方法的大量投資和資金
    • 任務
      • 肛瘺治療相關的複雜問題
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章肛瘺治療市場：依治療類型

  • 非手術的
  • 外科

第7章肛瘺治療市場：按瘻管類型

  • 括約肌間瘻管
  • 括約肌上瘻管
  • 經括約肌瘻

第8章肛瘺治療市場：依最終使用者分類

  • 門診手術中心
  • 醫院

第9章 北美和南美肛門瘺治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太肛瘺治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲肛門瘺治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • Cook Group Incorporated
    • Integra LifeSciences Corporation
    • Johnson & Johnson Services, Inc.
    • KARL STORZ SE & Co. KG
    • Novartis AG
    • Pfizer Inc.
    • Signum Surgical
    • Surtex Instruments Limited
    • Takeda Pharmaceutical Company Limited
    • THD SpA
    • WL Gore & Associates, Inc.
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-8E22B61932E1

[180 Pages Report] The Anal Fistula Treatment Market size was estimated at USD 651.39 million in 2023 and expected to reach USD 675.52 million in 2024, at a CAGR 4.87% to reach USD 909.10 million by 2030.

Global Anal Fistula Treatment Market

KEY MARKET STATISTICS
Base Year [2023] USD 651.39 million
Estimated Year [2024] USD 675.52 million
Forecast Year [2030] USD 909.10 million
CAGR (%) 4.87%
Anal Fistula Treatment Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anal Fistula Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anal Fistula Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anal Fistula Treatment Market, highlighting leading vendors and their innovative profiles. These include Cook Group Incorporated, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, Novartis AG, Pfizer Inc., Signum Surgical, Surtex Instruments Limited, Takeda Pharmaceutical Company Limited, THD SpA, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Anal Fistula Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment Type
    • Non-Surgical
    • Surgical
  • Fistula Type
    • Intersphincteric Fistula
    • Suprasphincteric Fistula
    • Transsphincteric Fistula
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anal Fistula Treatment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anal Fistula Treatment Market?

3. What are the technology trends and regulatory frameworks in the Anal Fistula Treatment Market?

4. What is the market share of the leading vendors in the Anal Fistula Treatment Market?

5. Which modes and strategic moves are suitable for entering the Anal Fistula Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Anal Fistula Treatment Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in prevalence of anal fistula among individuals worldwide
      • 5.1.1.2. Inclination towards minimally invasive surgical procedure
      • 5.1.1.3. Rise in approval rate for drugs and therapies for anal fistula treatment
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of anal fistula treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of novel treatments for anal fistula
      • 5.1.3.2. Significant investment and funding for development of enhanced drugs and treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with anal fistula treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Anal Fistula Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Non-Surgical
  • 6.3. Surgical

7. Anal Fistula Treatment Market, by Fistula Type

  • 7.1. Introduction
  • 7.2. Intersphincteric Fistula
  • 7.3. Suprasphincteric Fistula
  • 7.4. Transsphincteric Fistula

8. Anal Fistula Treatment Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals

9. Americas Anal Fistula Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Anal Fistula Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Anal Fistula Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Cook Group Incorporated
    • 13.1.2. Integra LifeSciences Corporation
    • 13.1.3. Johnson & Johnson Services, Inc.
    • 13.1.4. KARL STORZ SE & Co. KG
    • 13.1.5. Novartis AG
    • 13.1.6. Pfizer Inc.
    • 13.1.7. Signum Surgical
    • 13.1.8. Surtex Instruments Limited
    • 13.1.9. Takeda Pharmaceutical Company Limited
    • 13.1.10. THD SpA
    • 13.1.11. W. L. Gore & Associates, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANAL FISTULA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ANAL FISTULA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANAL FISTULA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANAL FISTULA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANAL FISTULA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANAL FISTULA TREATMENT MARKET DYNAMICS
  • FIGURE 7. ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2023 VS 2030 (%)
  • FIGURE 10. ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ANAL FISTULA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ANAL FISTULA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANAL FISTULA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANAL FISTULA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANAL FISTULA TREATMENT MARKET SIZE, BY NON-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANAL FISTULA TREATMENT MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. ANAL FISTULA TREATMENT MARKET SIZE, BY INTERSPHINCTERIC FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANAL FISTULA TREATMENT MARKET SIZE, BY SUPRASPHINCTERIC FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANAL FISTULA TREATMENT MARKET SIZE, BY TRANSSPHINCTERIC FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 13. ANAL FISTULA TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANAL FISTULA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. ANAL FISTULA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 143. ANAL FISTULA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. ANAL FISTULA TREATMENT MARKET LICENSE & PRICING